American Heart Journal
Volume 156, Issue 6 , Pages 1110-1116, December 2008

Prognostic value of left atrial volume in patients who underwent dobutamine stress echocardiography for known or suspected coronary artery disease

  • Jeane Mike Tsutsui, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
    • Corresponding Author InformationReprint requests: Jeane Mike Tsutsui, MD, Heart Institute (InCor)-University of São Paulo Medical School, Avenida Dr, Enéas Carvalho de Aguiar, 44, Sao Paulo CEP:05403-000, Brazil.
  • ,
  • Paulo M.M. Dourado, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
  • ,
  • Abdou Elhendy, MD

      Affiliations

    • Department of Cardiology-Marshfield Clinic, Marshfield, WI
  • ,
  • Sandra N.R.S. Falcão, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
  • ,
  • Renise M. Goes, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
  • ,
  • Antônio C.P. Chagas, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
  • ,
  • Protásio L. da Luz, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
  • ,
  • José A.F. Ramires, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil
  • ,
  • Wilson Mathias Jr, MD

      Affiliations

    • Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil

Received 16 December 2007; accepted 21 July 2008. published online 09 October 2008.

Background

Left atrial volume indexed (LAVI) has been reported as a predictor of cardiovascular events. We sought to determine the prognostic value of LAVI for predicting the outcome of patients who underwent dobutamine stress echocardiography (DSE) for known or suspected coronary artery disease (CAD).

Methods

From January 2000 to July 2005, we studied 981 patients who underwent DSE and off-line measurements of LAVI. The value of DSE over clinical and LAVI data was examined using a stepwise log-rank test.

Results

During a median follow-up of 24 months, 56 (6%) events occurred. By univariate analysis, predictors of events were male sex, diabetes mellitus, previous myocardial infarction, left ventricular ejection fraction (LVEF), left atrial diameter indexed, LAVI, and abnormal DSE. By multivariate analysis, independent predictors were LVEF (relative risk [RR] = 0.98, 95% CI 0.95-1.00), LAVI (RR = 1.04, 95% CI 1.02-1.05), and abnormal DSE (RR = 2.70, 95% CI 1.28-5.69). In an incremental multivariate model, LAVI was additional to clinical data for predicting events (χ2 36.8, P < .001). The addition of DSE to clinical and LAVI yielded incremental information (χ2 55.3, P < .001). The 3-year event-free survival in patients with normal DSE and LAVI ≤33 mL/m2 was 96%; with abnormal DSE and LAVI ≤33 mL/m2, 91%; with normal DSE and LAVI >34 mL/m2, 83%; and with abnormal DSE and LAVI >34 mL/m2, 51%.

Conclusion

Left atrial volume indexed provides independent prognostic information in patients who underwent DSE for known or suspected CAD. Among patients with normal DSE, those with larger LAVI had worse outcome, and among patients with abnormal DSE, LAVI was still predictive.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by FAPESP- Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo, Brazil.

PII: S0002-8703(08)00648-0

doi:10.1016/j.ahj.2008.07.015

American Heart Journal
Volume 156, Issue 6 , Pages 1110-1116, December 2008